Search results for “Phosphoinositide 3-kinase inhibitor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 381 patents, we discovered top 32 key players by total patent application. F. Hoffmann-La Roche Ltd., Genentech, Inc., Curis, Inc. are dominant in this area. They take 52.76% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 78
Genentech, Inc.
California, United States
Patent: 69
Curis, Inc.
Massachusetts, United States
Patent: 54
Novartis AG
Basel-Stadt, Switzerland
Patent: 47
Karus Therapeutics Ltd.
Hampshire, United Kingdom
Patent: 42
CHIESI Farmaceutici SpA
Emilia-Romagna, Italy
Patent: 26
RespiVert Ltd.
Buckinghamshire, United Kingdom
Patent: 16
Convalife Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 16
Jinan Shuaihua Pharmaceutical Technology Co., Ltd.
Shandong Sheng, China
Patent: 15
Shandong Lanjin Pharmaceuticals Co.,Ltd
Shandong Sheng, China
Patent: 11
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Stemirna Therapeutics Co. Ltd.
Shanghai Shi, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Karus Therapeutics Ltd., Stemirna Therapeutics Co. Ltd., Forschungsverbund Berlin eV take 33.33% of patent filing during this period.
Karus Therapeutics Ltd.
Hampshire, United Kingdom
Patent: 3
STARTUP
Stemirna Therapeutics Co. Ltd.
Shanghai Shi, China
Patent: 2
Forschungsverbund Berlin eV
Berlin, Germany
Patent: 2
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 2
Curis, Inc.
Massachusetts, United States
Patent: 2
Convalife Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 2
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 1
Venthera, Inc.
California, United States
Patent: 1
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
IFOM Fondazione Istituto FIRC di Oncologia Molecolare
Lombardia, Italy
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents in last 5 years, we discover 4 new entrants. Stemirna Therapeutics Co. Ltd., Forschungsverbund Berlin eV, Innovent Biologics (Suzhou) Co. Ltd. are the most active new entrants in this area.
STARTUP
Stemirna Therapeutics Co. Ltd.
Shanghai Shi, China
Patent: 2
Forschungsverbund Berlin eV
Berlin, Germany
Patent: 2
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 1
Venthera, Inc.
California, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 20 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Council of Scientific & Industrial Research
Delhi, India
Patent: 4
Washington University in St. Louis
Missouri, United States
Patent: 4
Universidade Federal do Rio Grande do Sul
Rio Grande do Sul, Brazil
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: